Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Investigational Lubricating Eye Drops (Johnson & Johnson Vision Care) is a preservative-free ophthalmic solution developed for the management of dry eye syndrome, specifically evaluated for its impact on visual acuity in contact lens wearers. The formulation is designed for delivery via a multidose preservative-free (MDPF) system, such as the Novelia eyedropper, which utilizes a one-way valve and silicone membrane to maintain sterility without the need for traditional preservatives like benzalkonium chloride. While the exact composition is investigational, it is likely based on the Blink Tears profile, utilizing demulcents and lubricants such as polyethylene glycol 400 and sodium hyaluronate to stabilize the tear film and provide long-lasting ocular surface protection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Investigational Lubricating Eye Drops (Johnson & Johnson Vision Care).